HIMS
Hims & Hers Health, Inc.
NYSE · USHealthcareMedical - Equipment & Services
$32.70-0.43%
Price as of Jul 20, 2026
HIMS growth
Hims & Hers Health, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +32.8%
- EBITDA
- -77.7%
- EBIT
- -71.6%
- EPS
- —
- Free cash flow
- -67.9%
- Operating cash flow
- -15.2%
Forward estimates
- Revenue
- +27.5%
- EBITDA
- +1053.6%
- EPS
- +1374.7%
Three-year CAGR
- Revenue
- +64.5%
- EBITDA
- +100.9%
- EBIT
- +70.6%
- Net income
- +1.8%
- EPS
- -1.7%
- Free cash flow
- +25.5%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.